Category: Latest News

Mark Zuckerberg, CEO of Meta (NASDAQ:META), shared his vision for delivering “personal superintelligence” to everyone, setting Meta’s AI strategy apart from its rivals. In a statement released Wednesday, Zuckerberg revealed that Meta’s AI systems have started to show signs of self-improvement, making the arrival of superintelligence “now in sight” over the coming years. “Meta’s vision…

Federal Signal Corporation (NYSE:FSS) saw its shares rise 5% in premarket trading after reporting second-quarter earnings that beat analyst expectations and prompting the company to raise its full-year guidance. The provider of environmental and safety solutions posted adjusted earnings per share of $1.17 for the quarter ended June 30, topping the analyst consensus of $1.06.…

LENZ Therapeutics, Inc. (NASDAQ:LENZ) saw its stock rise 6.1% in premarket trading following the release of its second-quarter financial report and confirmation that the FDA’s decision on its New Drug Application (NDA) for LNZ100 remains on track for August 8, 2025. The biopharmaceutical company, currently in the pre-commercial phase, posted a second-quarter loss of $0.53…

Verisk Analytics Inc (NASDAQ:VRSK) saw its shares climb 3% in premarket trading following the release of second-quarter results that exceeded analyst expectations, along with an upward revision to its revenue forecast for 2025. The data analytics firm reported adjusted earnings per share of $1.88 for the quarter ended June 30, outperforming the consensus estimate of…

Sleep Number Corporation (NASDAQ:SNBR) saw its shares plunge 21.3% in premarket trading following the release of second-quarter results that fell far short of analyst forecasts. The smart bed maker also issued a weaker full-year outlook, underscoring the ongoing challenges in its turnaround strategy. The company reported a loss of $1.09 per share for Q2, a…

Hess Midstream LP (NYSE:HESM) reported second-quarter earnings that outpaced analyst expectations, with adjusted EPS of $0.74 beating the consensus estimate of $0.66. Revenue also topped forecasts, reaching $414.2 million compared to the anticipated $405.13 million. Net income rose 19.3% year-over-year to $179.7 million from $160.3 million in the same quarter last year, while revenue increased…

Graham Holdings Company (NYSE:GHC) saw its stock climb 2.1% following the release of its second-quarter results, which notably exceeded analyst projections and highlighted strong performance across several business areas. For Q2 2025, the diversified media and education firm posted adjusted earnings per share of $14.33, well above the expected $10.15. Revenues increased 3% year-over-year to…

Coinbase (NASDAQ:COIN) stock rose 1.5% after the crypto exchange announced a strategic collaboration with JPMorgan Chase (NYSE:JPM) aimed at making digital asset access easier for mainstream bank users. The partnership introduces new tools that allow Chase customers to connect their bank accounts directly to Coinbase wallets through JPMorgan’s secure API. This bank-to-wallet integration will streamline…

Incannex Healthcare Inc. (NASDAQ:IXHL) shares jumped 10% after the company announced encouraging Phase 2 trial results for its experimental sleep apnea treatment, IHL-42X. According to topline data from the RePOSA trial, the investigational oral therapy produced statistically significant improvements on several major endpoints for obstructive sleep apnea (OSA). In particular, IHL-42X reduced the Apnoea-Hypopnoea Index…

Shares of VYNE Therapeutics (NASDAQ:VYNE) plummeted 70% on Wednesday after the biopharmaceutical company revealed that its Phase 2b clinical trial for repibresib gel in nonsegmental vitiligo failed to meet both its primary and key secondary endpoints. The trial did not achieve the F-VASI50 benchmark at week 24, which measures the proportion of patients achieving at…